hims wegovy - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

Novo Nordisk ends Hims & Hers deal over Wegovy knockoffs

Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss drug.

Reuters on MSN · 4h

Novo Nordisk says WeightWatchers will sell Wegovy, announces $299 price

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1.

The Wall Street Journal on MSN · 6h

Novo Nordisk to Expand Access to Wegovy With WeightWatchers Partnership

The pharmaceutical giant said WeightWatchers will work with CenterWell Pharmacy to fulfill and deliver Wegovy prescriptions.

4h

What's Going On With Hims & Hers Health Stock Today?

Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after ...

Medical Marketing & Media2h

Novo breaking up with Hims & Hers offers medical marketers a lesson

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

2d

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results